Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
2315Biotechnology
HK$42.00−2.19%As of Oct 29vs prior close
- Market cap
- $575.4M
- P/E (TTM)
- 10.5×
- P/E (FY1)
- 41.5×
- From 52W high
- −47.30%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥1.7B
- Net margin
- 21.56%
Nomior Score
72
Ascendant MoverTop 7% of the scored universe
Growth69
Quality63
Value49
Momentum96
Resilience40
Growth
+37.20%revenue a year over 3 fiscal years
YE22 CN¥533.9MLTM CN¥1.7B
Connections
Revenue to profitYE25
13% of revenue became net profit, up 9 pts on a year.